Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B ; volume:5 ; number:1 ; day:18 ; month:8 ; year:2016 ; pages:1-12 ; date:12.2016
Clinical and translational medicine ; 5, Heft 1 (18.8.2016), 1-12, 12.2016
- Urheber
-
Malecki, Marek
- Beteiligte Personen und Organisationen
-
Sabo, Chelsea
Foorohar, Afsoon
Tombokan, Xenia
SpringerLink (Online service)
- DOI
-
10.1186/s40169-016-0111-8
- URN
-
urn:nbn:de:1111-2016091512641
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Malecki, Marek
- Sabo, Chelsea
- Foorohar, Afsoon
- Tombokan, Xenia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Shifting the paradigm: engaging multicellular networks for cancer therapy
Exploiting innate immunity for cancer immunotherapy
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Scripture and Dissent: Engaging with the Neo-Patristic Paradigm of Modern Orthodox Theology
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Shifting the paradigm: engaging multicellular networks for cancer therapy
Exploiting innate immunity for cancer immunotherapy
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Scripture and Dissent: Engaging with the Neo-Patristic Paradigm of Modern Orthodox Theology
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Shifting the paradigm: engaging multicellular networks for cancer therapy
Exploiting innate immunity for cancer immunotherapy
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Scripture and Dissent: Engaging with the Neo-Patristic Paradigm of Modern Orthodox Theology
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm